These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 32319566)
21. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review. Deng Z; Wu J; Xu S; Chen F; Zhang Z; Jin A; Wang J Biomark Med; 2020 Feb; 14(2):141-150. PubMed ID: 32064893 [TBL] [Abstract][Full Text] [Related]
23. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma. Huang C; Sun Y; Ma S; Vadamootoo AS; Wang L; Jin C Pathol Res Pract; 2019 Jun; 215(6):152411. PubMed ID: 30987831 [TBL] [Abstract][Full Text] [Related]
24. Circulating miR-215-5p and miR-642a-5p as potential biomarker for diagnosis of osteosarcoma in Mexican population. Monterde-Cruz L; Ramírez-Salazar EG; Rico-Martínez G; Linares-González LM; Guzmán-González R; Delgado-Cedillo E; Estrada-Villaseñor E; Valdés-Flores M; Velázquez-Cruz R; Hidalgo-Bravo A Hum Cell; 2018 Oct; 31(4):292-299. PubMed ID: 29907935 [TBL] [Abstract][Full Text] [Related]
25. RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer. Cheng WC; Liao TT; Lin CC; Yuan LE; Lan HY; Lin HH; Teng HW; Chang HC; Lin CH; Yang CY; Huang SC; Jiang JK; Yang SH; Yang MH; Hwang WL Int J Cancer; 2019 Oct; 145(8):2209-2224. PubMed ID: 30980673 [TBL] [Abstract][Full Text] [Related]
26. Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients. Wang J; Zhang H; Sun X; Wang X; Ren T; Huang Y; Zhang R; Zheng B; Guo W J Nanobiotechnology; 2020 Oct; 18(1):151. PubMed ID: 33092576 [TBL] [Abstract][Full Text] [Related]
27. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p. Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551 [TBL] [Abstract][Full Text] [Related]
28. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis. Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606 [TBL] [Abstract][Full Text] [Related]
29. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748 [TBL] [Abstract][Full Text] [Related]
30. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1. Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663 [TBL] [Abstract][Full Text] [Related]
31. MiR-598: A tumor suppressor with biomarker significance in osteosarcoma. Liu K; Sun X; Zhang Y; Liu L; Yuan Q Life Sci; 2017 Nov; 188():141-148. PubMed ID: 28882648 [TBL] [Abstract][Full Text] [Related]
32. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer. Liu X; Chu KM J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma. Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525 [TBL] [Abstract][Full Text] [Related]
34. Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice. Taverna S; Giallombardo M; Gil-Bazo I; Carreca AP; Castiglia M; Chacártegui J; Araujo A; Alessandro R; Pauwels P; Peeters M; Rolfo C Oncotarget; 2016 May; 7(19):28748-60. PubMed ID: 26919248 [TBL] [Abstract][Full Text] [Related]
35. The potential roles of exosomal noncoding RNAs in osteosarcoma. Li S; Wang X J Cell Physiol; 2021 May; 236(5):3354-3365. PubMed ID: 33044018 [TBL] [Abstract][Full Text] [Related]
36. Detection of Plasma MicroRNA Signature in Osteosarcoma Patients. Allen-Rhoades W; Yustein JT Methods Mol Biol; 2018; 1699():113-118. PubMed ID: 29086373 [TBL] [Abstract][Full Text] [Related]
37. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma. Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733 [TBL] [Abstract][Full Text] [Related]
38. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells. Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333 [TBL] [Abstract][Full Text] [Related]
39. Translating microRNAs into biomarkers: What is new for pediatric cancer? de Carvalho IN; de Freitas RM; Vargas FR Med Oncol; 2016 May; 33(5):49. PubMed ID: 27085875 [TBL] [Abstract][Full Text] [Related]
40. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3. Tan Y; Chen L; Li S; Hao H; Zhang D Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]